However, in contrast to the most prevalent loss‐of‐function mutation of CHD7, such as nonsense mutation and frameshift deletion or insertion in CHARGE syndrome, the most frequent (86%) CHD7 mutations in human cancers were missense mutations. This evidence concerns the gene CHD7 and CHARGE syndrome.